mRNA beta gal (5moU) 

Cat.No. MRM-045

Description These mRNAs are produced by in vitro transcription and stabilized at the 5’ end by modified nucleotides capping (Cap1). They contain a poly(A) tail at the 3’ end and are also optimized to yield improved stability and performance. They are modified with 5-methoxyuridine (18moU replaces U) to reduce innate immune responses.
Size 100 µg
Benefits No nuclear uptake is required - proteins are directly expressed in the cytoplasm; Faster protein expression than DNA transfection; No genome integration; It is very suitable for transfection of slow or non dividing cells; The protein is expressed in a manner independent of the total promoter.
Storage Conditions -80°C
Applications β-galactosidase (β-gal) mRNA, codes for a protein product of the bacterial LacZ gene. β-gal catalyzes the conversion of β-galactosides into monosaccharides. It is a common marker gene used to assess transfection efficiency.
For research use only. Not intended for any clinical use.
Offer for you
Online inquiry
Copyright © 2024 Creative Biogene. All rights reserved.